World's Best Scientists 2026 revealed!
Evangelos D. Michelakis

Evangelos D. Michelakis

D-Index & Metrics

Medicine

D-Index
85
Citations
29355
World Ranking
14518
National Ranking
604

Evangelos D. Michelakis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Evangelos D. Michelakis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 286 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Evangelos D. Michelakis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Evangelos D. Michelakis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Evangelos D. Michelakis is affiliated with the University of Alberta in Canada. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Epidemiology, and Oncology.

The scientist's work covers a range of key topics:

  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Function and Risk Factors
  • RNA modifications and cancer
  • Prostate Cancer Treatment and Research
  • Cancer, Hypoxia, and Metabolism
  • Mitochondrial Function and Pathology
  • Prostate Cancer Diagnosis and Treatment

Recent publications by Evangelos D. Michelakis include:

  • "Mechanical Stiffness Controls Dendritic Cell Metabolism and Function," 2021, published in Cell Reports
  • "Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation state," 2022, published in Cell Metabolism
  • "MFN2-driven mitochondria-to-nucleus tethering allows a non-canonical nuclear entry pathway of the mitochondrial pyruvate dehydrogenase complex," 2022, published in Molecular Cell
  • "TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure," 2022, published in Science Translational Medicine
  • "Fluorine-18 Prostate-Specific Membrane Antigen-1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer," 2024, published in JAMA Oncology

The scientist frequently publishes in venues such as:

  • Circulation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • The Journal of Urology
  • Science Translational Medicine

Frequent co-authors collaborating with Evangelos D. Michelakis include:

  • Gopinath Sutendra
  • Yongneng Zhang
  • Alois Haromy
  • Bruno Saleme
  • Adam Kinnaird

Best Publications

  • A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

    Sébastien Bonnet;Stephen L. Archer;Joan Allalunis-Turner;Alois Haromy

  • Metabolic Modulation of Glioblastoma with Dichloroacetate

    E. D. Michelakis;G. Sutendra;P. Dromparis;L. Webster

  • Inflammation, growth factors, and pulmonary vascular remodeling.

    Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi

  • Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

    E D Michelakis;L Webster;J R Mackey

  • An Abnormal Mitochondrial–Hypoxia Inducible Factor-1α–Kv Channel Pathway Disrupts Oxygen Sensing and Triggers Pulmonary Arterial Hypertension in Fawn Hooded Rats Similarities to Human Pulmonary Arterial Hypertension

    Sébastien Bonnet;Evangelos D. Michelakis;Christopher J. Porter;Miguel A. Andrade-Navarro

  • Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide

    Evangelos Michelakis;Wayne Tymchak;Dale Lien;Linda Webster

  • Vascular Endothelial Growth Factor Gene Therapy Increases Survival, Promotes Lung Angiogenesis, and Prevents Alveolar Damage in Hyperoxia-Induced Lung Injury Evidence That Angiogenesis Participates in Alveolarization

    Bernard Thébaud;Faruqa Ladha;Evangelos D. Michelakis;Monika Sawicka

  • Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension

    Evangelos D. Michelakis;Wayne Tymchak;Dale Lien;Linda DaSilva

  • Relevant issues in the pathology and pathobiology of pulmonary hypertension

    Rubin M Tuder;Stephen L Archer;Peter Dorfmüller;Serpil C Erzurum

  • Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility

    Jayan Nagendran;Stephen L. Archer;Daniel Soliman;Vikram Gurtu

  • Hypoxic pulmonary vasoconstriction.

    Rohit Moudgil;Evangelos D. Michelakis;Stephen L. Archer

  • Comprehensive Invasive and Noninvasive Approach to the Right Ventricle–Pulmonary Circulation Unit State of the Art and Clinical and Research Implications

    Hunter C. Champion;Evangelos D. Michelakis;Evangelos D. Michelakis;Paul M. Hassoun

  • Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis

    M. Sean McMurtry;Sebastien Bonnet;Xichen Wu;Jason R.B. Dyck

  • A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation

    Gopinath Sutendra;Adam Kinnaird;Peter Dromparis;Roxane Paulin

  • Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

    Evangelos D. Michelakis;Wayne Tymchak;Michelle Noga;Linda Webster

  • Dichloroacetate, a Metabolic Modulator, Prevents and Reverses Chronic Hypoxic Pulmonary Hypertension in Rats Role of Increased Expression and Activity of Voltage-Gated Potassium Channels

    Evangelos D. Michelakis;M. Sean McMurtry;Xi Chen Wu;Jason R.B. Dyck

  • Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension

    M. Sean McMurtry;Stephen L. Archer;Dario C. Altieri;Sebastien Bonnet

  • The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted

    Sebastien Bonnet;Gael Rochefort;Gopinath Sutendra;Stephen L. Archer

  • Differential Distribution of Electrophysiologically Distinct Myocytes in Conduit and Resistance Arteries Determines Their Response to Nitric Oxide and Hypoxia

    Stephen L. Archer;James M.C. Huang;Helen L. Reeve;Václav Hampl

  • Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction A Phase IIb Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Hemodynamic Study

    Diana Bonderman;Stefano Ghio;Stephan B. Felix;Hossein Ardeschir Ghofrani

Frequent Co-Authors

Stephen L. Archer
Stephen L. Archer Queen's University
Jason R.B. Dyck
Jason R.B. Dyck University of Alberta
Gary D. Lopaschuk
Gary D. Lopaschuk University of Alberta
Robert C. Robbins
Robert C. Robbins Stanford University
Gavin Y. Oudit
Gavin Y. Oudit University of Alberta
Paul M. Hassoun
Paul M. Hassoun Johns Hopkins University
Marlene Rabinovitch
Marlene Rabinovitch Stanford University
Dario C. Altieri
Dario C. Altieri The Wistar Institute
William C. Sessa
William C. Sessa Pfizer (United States)
Serpil C. Erzurum
Serpil C. Erzurum Cleveland Clinic Lerner College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a range of related online degrees and career pathways. Students who are interested in nutrition and health can consider enrolling in the best online food science degree programs, which cover key areas like dietetics, food safety, and public health.

If your interests lean toward hospital operations and leadership, it is essential to learn how to evaluate healthcare administration degree programs before enrolling. Accreditation, curriculum, and career outcomes are important factors to consider.

For nurses looking to advance their qualifications, flexible rn to bsn programs offer a path to higher earning potential and broader clinical roles—sometimes without any required clinical hours.

Experienced nurses seeking leadership or specialized roles can look into accelerated dnp programs, which provide advanced practice and doctorate-level credentials in a shorter timeframe.

Best Scientists Citing Evangelos D. Michelakis

Trending Scientists

Recently Published Articles